Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina. (Q45390397)

From Wikidata

Jump to navigation Jump to search

scientific article published in December 2008

Language	Label	Description	Also known as
English	Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina.	scientific article published in December 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18835312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18835312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

0 references

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18835312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

author name string

Eduardo Maradei

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18835312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

José La Torre

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18835312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Blanca Robiolo

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18835312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Jorge Esteves

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18835312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Cristina Seki

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18835312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Andrea Pedemonte

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18835312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Marcela Iglesias

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18835312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Ricardo D'Aloia

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18835312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

language of work or name

0 references

publication date

1 December 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18835312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18835312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18835312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

51

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18835312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

6577-6586

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18835312%20AND%20SRC:MED&resulttype=core&format=json

15 January 2020

Evolution of foot-and-mouth disease virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.033

7 January 2021

Control and eradication of foot-and-mouth disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.033

7 January 2021

Foot-and-mouth disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.033

7 January 2021

The suitability of the 'emergency' foot-and-mouth disease antigens held by the International Vaccine Bank within a global context

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.033

7 January 2021

European Pharmacopoeia foot-and-mouth disease vaccine potency testing in cattle: between test variability and its consequences

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.033

7 January 2021

Potency control of foot-and-mouth disease vaccine in cattle. Comparison of the 50% protective dose and the protection against generalization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.033

7 January 2021

Foot and mouth disease vaccine potency tests in cattle: the interrelationship of antigen dose, serum neutralizing antibody response and protection from challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.033

7 January 2021

Comparison of a liquid-phase blocking sandwich ELISA and a serum neutralization test to evaluate immunity in potency tests of foot-and-mouth disease vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.033

7 January 2021

Potency assessment of foot-and-mouth disease vaccines in cattle by means of antibody assays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.033

7 January 2021

Indirect foot-and-mouth disease vaccine potency testing based on a serological alternative

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.033

7 January 2021

Large-scale use of liquid-phase blocking sandwich ELISA for the evaluation of protective immunity against aphthovirus in cattle vaccinated with oil-adjuvanted vaccines in Argentina

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.033

7 January 2021

Assessment of foot and mouth disease vaccine potency by liquid-phase blocking ELISA: a proposal for an alternative to the challenge procedure in Argentina

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.033

7 January 2021

Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.033

7 January 2021

Analysis of the immune response to FMDV structural and non-structural proteins in cattle in Argentina by the combined use of liquid phase and 3ABC-ELISA tests.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.033

7 January 2021

Foot-and-mouth disease vaccine potency testing in cattle using homologous and heterologous challenge strains: Precision of the “Protection against Podal Generalisation” test

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.033

7 January 2021

Improvement of a serodiagnostic strategy for foot-and-mouth disease virus surveillance in cattle under systematic vaccination: a combined system of an indirect ELISA-3ABC with an enzyme-linked immunoelectrotransfer blot assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.033

7 January 2021

A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. I. Development and method of ELISA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.033

7 January 2021

A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. II. Application

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.033

7 January 2021

Enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. III. Evaluation of antibodies after infection and vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.033

7 January 2021

Validation of serological assays for diagnosis of infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.033

7 January 2021

Modeling and Computer Simulation Approach to the Mechanism of Foot-and-Mouth Disease Virus Neutralization Assays

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.033

7 January 2021

A Coefficient of Agreement for Nominal Scales

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.033

7 January 2021

Large sample standard errors of kappa and weighted kappa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.033

7 January 2021

Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.033

7 January 2021

Evaluation of a monoclonal antibody-based approach for the selection of foot-and-mouth disease (FMD) vaccine strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.09.033

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45390397&oldid=1403537927"